Filing
3rd Quarter - Report
Lobbying activity
1
Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, and PBM reform.